Clinical Trials List
2021-01-01 - 2029-10-31
Phase III
Recruiting7
ICD-10C67.0
Malignant neoplasm of trigone of bladder
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9188.0
Malignant neoplasm of trigone of urinary bladder
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- YI-KAI CHANG 未分科
- 曾啟新 未分科
- FU-JEN HSUEH 未分科
- CHING-CHU LU 未分科
- Yeong-Shiau Pu 未分科
- JIAN-HUA HONG 未分科
- Yu-Chieh Tsai 未分科
- Chia-Hsien Chen 未分科
- 王中傑 未分科
- CHUNG-HSIN CHEN 未分科
- PO-MING CHOW 未分科
- JHE-CYUAN GUO 未分科
- 呂紹綸 未分科
- YU-CHUAN LU 未分科
- SHUO-MENG WANG 未分科
- Ying-Chun Shen 未分科
- - - 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hung-Lung Ke Division of Urology
- 李政學 未分科
- 黃俊農 Division of Urology
- Chih-Jen Huang Division of Radiation Therapy
- Tsung-Yi Huang 未分科
- Jeng-Shiun Du Division of Hematology & Oncology
- 阮雍順 Division of Urology
- Ching-Chia Li Division of Urology
- Tsu-Ming Chien Division of Urology
- 張顥瀚 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Ping Huang 未分科
- Yi-Huei Chang 未分科
- Ching-Chan Lin 未分科
- 賴宥良 未分科
- Chi-Rei Yang 未分科
- Po-Jen Hsiao 未分科
- Che-Hung Lin 未分科
- Han Chang 未分科
- Chao-Hsiang Chang 未分科
- Yu-De Wang 未分科
- Ji-An Liang 未分科
- Wei-Ching Lin 未分科
- Po-Fan Hsieh 未分科
- Su-Peng Yeh 未分科
- Yu-Cheng Kuo 未分科
- 謝德鈞 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Wen-Pin Su Division of Hematology & Oncology
- Jiann-Hui Ou Division of Hematology & Oncology
- Kwang-Yu Chang Division of Hematology & Oncology
- Che-Yuan Hu Division of Hematology & Oncology
- 薛尉廷 Division of Radiation Therapy
- Kuan-Yu Wu Division of Hematology & Oncology
- Liu Yi-Sheng Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- See-Tong Pang Division of Hematology & Oncology
- Yuan-Cheng Chu N/A
- 張境夫 Division of Hematology & Oncology
- 黃亮鋼 N/A
- Kai-Jie Yu Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
- 黃文冠 Division of Hematology & Oncology
- Rita cheng Division of Hematology & Oncology
- 吳俊德 Division of Hematology & Oncology
- PO-HUNG LIN Division of Hematology & Oncology
- I-hung Shao Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- 詹頂立 Division of Radiation Therapy
- 林柏宏 未分科
- Hong-Cheng Gan Division of Hematology & Oncology
- 吳燿宇 Division of Radiation Therapy
- 沈鼎文 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 熊小澐 N/A
- 盧嘉文 N/A
- 梅承恩 Division of Urology
- 游惟強 N/A
- Shian-Shiang Wang Division of Urology
- Cheng-Che Chen Division of Urology
- 林雁婷 Division of Radiology
- JU-CHUAN HU Division of Urology
- Chuan-Shu Chen Division of Urology
- Chia-Yen Lin Division of Urology
- 王樹吉 Division of Urology
- 廖博崎 Division of Urology
- 裘坤元 Division of Urology
- Jian-Ri Li Division of Urology
- 洪晟鈞 Division of Urology
- 張瓈文 Division of Urology
- 賴谷順 Division of Urology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
550 participants
